Award-winning physician Kenneth D. Nahum works as a hematologist and oncologist at Regional Cancer Care Associates in New Jersey. Possessing more than three decades of experience, Dr. Kenneth D. Nahum has treated a wide range of cancers, including non-small cell lung cancer (NSCLC).
Roughly 80 percent to 85 percent of all lung cancers are classified as NSCLC. This classification is based on the microscopic appearance of the tumor cells.
The bulk of NSCLC cancers in the United States are adenocarcinomas. While these cancers are associated with smoking, they can also appear in people who do not smoke. Most often, adenocarcinomas develop in the outer areas of the lungs and spread to the lymph nodes and then throughout the body.
After adenocarcinomas, the most common form of NSCLC is squamous cell carcinoma. Roughly 25 percent to 30 percent of all lung cancer cases involve squamous cell carcinomas.
In most cases, these types of cancer grow in the central chest area in the bronchi. From there, they can spread to the lymph nodes, but they normally stay in the lungs.
Finally, about 10 percent to 15 percent of all lung cancers are categorized as large-cell or undifferentiated carcinomas. An aggressive form of lung cancer, large-cell carcinomas rapidly spread to the lymph nodes and other areas of the body.
This aggressive nature is also seen in small-cell lung cancers (SCLC), the classification that includes all lung cancers not in the NSCLC category.
Specializing in treating patients with blood cancers and other blood disorders, Kenneth D. Nahum, DO, has served as a hematologist and oncologist with Regional Cancer Care Associates, LLC, since 2012. Continually honing his education in the field, Dr. Kenneth D. Nahum belongs to the American Society of Clinical Oncology (ASCO).
A recent study featured in JAMA: The Journal of the American Medical Association shows that economic background can play a significant role in the quality of cancer care that patients receive. ASCO President Monica M. Bertagnolli, MD, FACS, FASCO, commented on the study’s findings by affirming the conclusion that advances in cancer care have not always translated into better outcomes, especially for those who come from low-income backgrounds.
ASCO also joined JAMA researchers in urging policymakers and other stakeholders to push for public health initiatives targeting underserved areas to help them get access to better cancer care. The organization has been partnering with local health departments to provide smoking cessation courses and says it will continue to work with other public health entities to address other issues, such as smoking, obesity, and lack of physical activity, that tend to be more prevalent in patients from lower-income backgrounds.
Award-winning physician Kenneth D. Nahum practices with Regional Cancer Care Associates (RCCA) as a hematologist and oncologist. Possessing more than three decades of experience, Dr. Kenneth D. Nahum has helped thousands of patients with various disorders, including hemophilia.
An inherited disorder on the X chromosome, hemophilia prevents the proper clotting of blood. Since women inherit two X chromosomes, one from each parent, they are less likely to develop hemophilia than men.
The presence of a second X chromosome prevents the development of this condition in many women, providing a second copy of the same genes. Men do not have this second copy since they have one X chromosome and one Y chromosome, which allows the mutated X chromosome to have more of an impact.
In most cases, women are carriers of hemophilia. However, about a third of these women also display mild hemophilia symptoms, such as impaired blood clotting. These women may have approximately 30 to 70 percent of the blood-clotting ability of someone who is not a carrier of the hemophilia mutation.
Carriers may experience heavy menstrual periods characterized by clots larger than a quarter, bleeding for more than seven days, or a large amount of blood that limits daily activities. Heavy bleeding from childbirth or dental surgery is also common among women who carry the hemophilia mutation.
Some women are diagnosed with hemophilia because they either inherited a mutated X chromosome from both parents, meaning they have two mutated X chromosomes, or their non-mutated X chromosome is either inactive or missing. This situation is extremely rare, but it does result in hemophilia symptoms similar to the symptoms in males with hemophilia.
Treating patients at Regional Cancer Care Associates, LLC, Kenneth D. Nahum, DO, is a hematologist and an oncologist who also performs clinical research. Frequently recognized for his philanthropic work, Dr. Kenneth D. Nahum and his wife were honored by Solomon Schechter Day School of Monmouth County for their support.
Established in 1979 on the foundation of conservative Judaism, Solomon Schechter Day School of Greater Monmouth County recently changed its named to The Hebrew Academy. Focused on guiding Jewish youth to becoming responsible, informed, and devout adults, the school provides instruction that is based on traditional Jewish texts.
In addition to studying the Torah, students participate in service projects, including food drives, nursing home visits, and community clean-up projects. Students at The Hebrew Academy also study both modern and biblical versions of Hebrew. The introductory language program, called Mechina, allows those even with no background in Hebrew to study at their own pace.
A Howell, New Jersey, medical practitioner, Kenneth D. Nahum, DO, provides knowledgeable hematology and oncology care for patients living with cancer and blood disorders. Areas in which Dr. Kenneth D. Nahum has extensive experience include autologous stem cell transplantation, which involves the replacement of the blood stem cells, which are needed to generate new blood cells.
Typically undertaken in tandem with high-dose chemotherapy associated with lymphoma, the process starts before chemotherapy with the collection and storage of one’s own blood stem cells. This requires “mobilization,” or the transfer of stem cells from the bone marrow into the bloodstream, and is accomplished via daily injections of G-CSF or a similar naturally occurring growth factor. This stimulates the bone marrow to produce more stem cells than usual and encourages their movement into the bloodstream.
With growth factor injections lasting 7-10 days, side effects are usually minimal and include bone and muscle aches and pains. Once a sufficient number of stem cells have accumulated in the bloodstream, a cell separation device is employed to separate stem cells from blood extracted from one arm before returning the blood to the other arm. This stem cell material is then stored until after chemotherapy when it can be returned to the bloodstream and used to replenish the body’s stores.
Kenneth D. Nahum, DO, an oncologist and hematologist with Regional Cancer Care Associates, LLC, in Howell, New Jersey, has helped others throughout his three-decade medical career. In partnership with Cross-Cultural Solutions, Dr. Kenneth D. Nahum worked with children with disabilities in Guatemala.
Cross-Cultural Solutions operates two major programs in Guatemala. One program focuses on childhood education, while the other focuses on children’s health.
Guatemalan schools lack basic resources and have difficulty retaining students after the sixth grade. These conditions make it difficult for these children to escape poverty. Cross-Cultural Solutions partners with local schools to provide resources for education and support engaging activities and lesson plans.
The health system in Guatemala is underfunded, and Cross-Cultural Solutions works to provide public health services that directly benefit children. Common issues include vision and dental care, as well as improvement of sanitation services locally. Through the installation of hand washing stations and disease prevention workshops, it also works to curb the spread of disease.
Experienced in the fields of hematology and oncology, Kenneth D. Nahum, DO, has spent 30 years providing care for thousands of patients with cancer and blood disorders. In 2006, The Ashley Lauren Foundation (ALF), a nonprofit organization dedicated to pediatric cancer patients, honored Dr. Kenneth D. Nahum, together with his wife and children, for his contributions to the organization.
Monica Vermeulen, the mother of cancer survivor Ashley Lauren, established ALF to help pediatric cancer patients and their families face the daily battles brought about by the disease. Operating independently and with the support of the community in New Jersey, ALF not only provides financial and emotional assistance, but also offers programs, including the following, designed to inspire and encourage the children:
- Hope Bag. During a child’s hospital visit, he or she brings this large tote bag that contains fun items and necessities such as toiletries and healthy snacks. More than the content of the bag, the Hope Bag is meant to bring hope, comfort, and love to a child and his or her family.
- Hospital Parties. ALF partners with different hospitals in the New Jersey area to coordinate holiday and season-themed parties for not only children receiving daily treatments as outpatients, but also inpatients who need to stay a few days for more treatments. The parties are packed with activities, arts and crafts, games, and more.
Board certified in hematology, internal medicine, and medical oncology, Kenneth D. Nahum practices with Regional Cancer Care Associates as a hematologist and oncologist. In this capacity, Kenneth D. Nahum has treated thousands of patients with various types of blood disorders.
A bleeding disorder characterized by poor blood clotting or abnormal bleeding, hemophilia is misunderstood by a large number of people. Following are three common misconceptions:
People outgrow it.
Since hemophilia is caused by a lack of a blood clotting protein, people do not outgrow the disorder. Nor does their hemophilia become less severe as they get older. In actuality, the amount of the blood clotting protein that a person has stays consistent throughout his or her life.
Minor cuts can kill someone with hemophilia.
In most cases, minor cuts are managed with a Band-Aid or other material to help the wound clot. These types of wounds are not fatal because hemophilia does not cause someone to bleed faster than normal. Internal bleeding is a concern for people with hemophilia, however, since their bodies are less capable of clotting properly.
Hemophilia is curable with the right vitamins and foods.
Unfortunately, vitamins and foods do not contain the essential clotting protein that people with hemophilia are missing. Certain vitamins or foods may control bleeding when taken at the time of an injury, but they cannot cure the disease.
An oncologist and hematologist in New Jersey, Kenneth D. Nahum divides his time between treating patients with cancer and blood disorders at Regional Cancer Care Associates and teaching at Robert Wood Johnson Medical School. Over the course of his career, Kenneth D. Nahum has conducted research into conditions such as colorectal cancer.
Roughly 96 percent of all colorectal cancers are adenocarcinomas. This type of colorectal cancer forms in the cells responsible for creating the mucus inside the rectum and colon. In most cases, it develops in the inner lining of the rectum and colon and spreads to other layers over time.
About 10 to 15 percent of all adenocarcinomas are mucinous. This subtype is more aggressive than normal adenocarcinomas because it primarily affects the mucus cells in the rectum and colon. Meanwhile, signet ring cell adenocarcinoma is rarer and accounts for less than 1 percent of adenocarcinomas. Another aggressive subtype, it is more difficult to treat.
There are also several less common types of colorectal cancers, including carcinoid tumors, gastrointestinal stromal tumors (GISTs), sarcomas, and lymphomas. Carcinoid tumors form in the intestines among hormone-making cells. They are usually slow-growing and account for about 1 percent of all colorectal cancers.
GISTs are typically found in the gastrointestinal tract and are a soft tissue sarcoma, a form of cancer that starts in the muscle layers, blood vessels, or other connective tissues. Lymphomas develop in the immune system cells in the rectum, colon, or other organs.
Kenneth D. Nahum received his medical training from the University of Medicine and Dentistry of New Jersey. He went on to pursue a career in hematology and oncology, and has been affiliated with the Regional Cancer Care Associates (RCCA) since 2012. Dr. Kenneth D. Nahum is also a member of the American Society of Clinical Oncology (ASCO).
ASCO, founded in 1964, is the premier professional organization for oncology professionals. The organization is at the forefront of policies and programs intended to guide oncologists in providing the best possible care for patients, including the Diversity in Oncology Initiative.
The Diversity in Oncology Initiative is a landmark strategic plan to provide a framework for increasing the racial and ethnic diversity within the oncology community. This ultimately aims to bring quality cancer care to minorities who otherwise would have difficulty accessing it. One aspect of the initiative is the Diversity Mentoring Program, which encourages medical students and residents belonging to minority populations to pursue a career in oncology. With the help of oncologists who would stand as mentors, physicians-in-training can receive much-needed career and educational guidance.
There is currently an underrepresentation of minority physicians in the medical field, especially in hematology and oncology. Less than six percent of the oncology workforce identifies as Hispanic and only around two percent as African-American – figures not congruent with the percentage of each demographic in the entire US population.
A practicing partner of Regional Cancer Care Associates, Dr. Kenneth D. Nahum, DO, has over 30 years of experience treating cancer patients in New Jersey and surrounding areas.